21-hydroxylase deficiency risk factors: Difference between revisions
No edit summary |
m (Mehdi Pahlavani moved page Congenital adrenal hyperplasia due to 21-hydroxylase deficiency risk factors to 21-hydroxylase deficiency risk factors without leaving a redirect) |
(No difference)
|
Revision as of 18:50, 18 July 2017
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency risk factors On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency risk factors |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Risk calculators and risk factors for 21-hydroxylase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
The most potent risk factors in the development of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is presence of family history of congenital adrenal hyperplasia due to 21-hydroxylase deficiency and being in certain ethnic groups, particularly Ashkenazi Jews and Yugoslavians and Yupik Inuits.
Risk Factors
The most potent risk factors in the development of congenital adrenal hyperplasia due to 21-hydroxylase deficiency are:
- Presence of family history of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
- People in certain ethnic groups, particularly Ashkenazi Jews and Yugoslavians and Yupik Inuits.[1][2]
References
- ↑ Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC (2010). "Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline". J. Clin. Endocrinol. Metab. 95 (9): 4133–60. doi:10.1210/jc.2009-2631. PMC 2936060. PMID 20823466.
- ↑ White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.